This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Servicio Andaluz De Salud, Universidad De Granada. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 17 
1 out of 21 
Years Active: 2022
Title: Innovator Spotlight: Pablo Bueno Laraño and His Contributions to Injectable Melatonin
Introduction: Pablo Bueno Laraño, a noteworthy inventor from Granada, Spain, has made significant strides in the field of pharmaceuticals with his innovative work on injectable melatonin formulations. With one patent to his name, he demonstrates a commitment to advancing medical technology that provides long-term stability for water-insoluble substances.
Latest Patents: Bueno Laraño's patent, titled "Durable Preparation of an Injectable of Melatonin Exhibiting Long-Term Stability," introduces an aqueous melatonin composition that showcases astonishing long-term stability. This innovative formulation allows for high concentrations of melatonin, which is typically water-insoluble. The advantages of this composition make it particularly beneficial for intravenous administration, enhancing its potential therapeutic uses.
Career Highlights: Throughout his career, Pablo Bueno Laraño has been associated with esteemed institutions, including the Servicio Andaluz de Salud and the Universidad de Granada. His contributions in these organizations have provided him with a platform to explore and refine his inventive ideas, particularly in the pharmaceutical sector.
Collaborations: Bueno Laraño has collaborated with notable professionals in his field, including Darío Acuña Castroviejo and Germaine Escames Rosa. These partnerships have fostered an environment of creativity and innovation, allowing for the cross-pollination of ideas and enhancing the development of his patented formulations.
Conclusion: Pablo Bueno Laraño exemplifies the spirit of innovation through his groundbreaking work on injectable melatonin preparations. His dedication to improving pharmaceutical formulations underscores the importance of sustained research and collaboration in the quest for medical advancements. As he continues to develop further innovations, the impact of his inventions promises to be felt in the medical community for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile